Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon

Open access
Rea, Mary C., Dobson, Alleson, O'Sullivan, Orla, Crispie, Fiona, Fouhy, Fiona, Cotter, Paul D., Shanahan, Fergus, Kiely, Barry, Hill, Colin, Ross, R. Paul · 2011 · Proceedings of the National Academy of Sciences

Abstract

Vancomycin, metronidazole, and the bacteriocin lacticin 3147 are active against a wide range of bacterial species, including Clostridium difficile. We demonstrate that, in a human distal colon model, the addition of each of the three antimicrobials resulted in a significant decrease in numbers of C. difficile. However, their therapeutic use in the gastrointestinal tract may be compromised by their broad spectrum of activity, which would be expected to significantly impact on other members of the human gut microbiota. We used high-throughput pyrosequencing to compare the effect of each antimicrobial on the composition of the microbiota. All three treatments resulted in a decrease in the proportion of sequences assigned to the phyla Firmicutes and Bacteroidetes, with a corresponding increase in those assigned to members of the Proteobacteria. One possible means of avoiding such "collateral damage" would involve the application of a narrow-spectrum antimicrobial with specific anti-C. difficile activity. We tested this hypothesis using thuricin CD, a narrow-spectrum bacteriocin produced by Bacillus thuringiensis, which is active against C. difficile. The results demonstrated that this bacteriocin was equally effective at killing C. difficile in the distal colon model but had no significant impact on the composition of the microbiota. This offers the possibility of developing a targeted approach to eliminating C. difficile in the colon, without collateral damage.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1001224107

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 461

Metadata

Authors
Rea, M. C., Dobson, A., O'Sullivan, O., Crispie, F., Fouhy, F., Cotter, P. D., Shanahan, F., Kiely, B., Hill, C., & Ross, R. P.
Affiliations
  • Teagasc - The Irish Agriculture and Food Development Authority (IE)
  • Teagasc, Moorepark Food Research Centre, Fermoy, County Cork, Ireland;
  • APC Microbiome Institute (IE)
  • Alimentary Health (Ireland) (IE)
  • University College Cork (IE)
Venue
Proceedings of the National Academy of Sciences
Published
2010-06-29
Volume
108
Issue
supplement_1
Pages
4639-4644
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2115717127
Cited by
377
References
39
Citations by year
2026: 11 · 2025: 19 · 2024: 23 · 2023: 28 · 2022: 29 · 2021: 21 · 2020: 26 · 2019: 31 · 2018: 21 · 2017: 32 · 2016: 30 · 2015: 25 · 2014: 27 · 2013: 24 · 2012: 15
FWCI
11.16
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
College of Engineering, Michigan State University
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
Clostridium difficile, vancomycin, metronidazole, lacticin 3147, bacteriocins, gut microbiota, microbial diversity, Firmicutes, Bacteroidetes, Proteobacteria, Clostridium difficile infection
MeSH terms
Anti-Bacterial Agents, Bacteriocins, Base Sequence, Colon, Feces, Humans, Metronidazole, Models, Biological, Molecular Sequence Data, Vancomycin, Clostridioides difficile, Sequence Analysis, DNA, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.